SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/276DC27717327718FFBED372DE1DEAFB558E8AE8D7C6861908974039DFCFC3D8CF8B3A7A9D41560C436790E55236A4AF>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/276DC27717327718FFBED372DE1DEAFB558E8AE8D7C6861908974039DFCFC3D8CF8B3A7A9D41560C436790E55236A4AF
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/276DC27717327718FFBED372DE1DEAFB558E8AE8D7C6861908974039DFCFC3D8CF8B3A7A9D41560C436790E55236A4AF
http://www.w3.org/2000/01/rdf-schema#comment
"miR132 was proposed to inhibit the proliferation and migration of diabetic rat or highglucosetreated vascular smooth muscle cells (VSMCs) by targeting E2F5"
xsd:string
http://purl.uniprot.org/uniprot/#_BC90862A28587D31A61158E77D539FA08CB9B5512617E83FA4DC3A6461406601A0798CF6008A96925831EF80C7A76D7D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/276DC27717327718FFBED372DE1DEAFB558E8AE8D7C6861908974039DFCFC3D8CF8B3A7A9D41560C436790E55236A4AF
http://purl.uniprot.org/uniprot/Q62814
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/276DC27717327718FFBED372DE1DEAFB558E8AE8D7C6861908974039DFCFC3D8CF8B3A7A9D41560C436790E55236A4AF
http://purl.uniprot.org/uniprot/#_Q62814-mappedCitation-31257477
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/276DC27717327718FFBED372DE1DEAFB558E8AE8D7C6861908974039DFCFC3D8CF8B3A7A9D41560C436790E55236A4AF